Prescription drug advertising and consumer stigma about depression: The moderating role of skepticism toward advertising

References

• Gellad F, Lyles KW. Direct-to-consumer advertising of pharmaceuticals. Am J Med 2007;120(6):475–80. doi: 10.1016/j.amjmed.2006.09.030
   PubMed Web of Science ®Google Scholar
• Kantar Media Intelligence. Ad$pender database. [cited 2015 Mar 10]. Available from: http://adspender.kantarmediana.com/adspender/Pages/Home.aspx.
   Google Scholar
• Mukherjee A, Limbu Y, Wanasika I. A review of research on direct-to-consumer advertising of prescription drugs: directions for future research. Int J Pharmaceut Healthc Market 2013;7(3):226–43. doi: 10.1108/IJPHM-07-2013-0037
   Google Scholar
• PhRMA. PhRMA chief medical officer testifies on DTC advertising. [updated 2005; cited 2015 Feb 22]. Available from: http://www.phrma.org/publications/testimony_and_official_submissions/phrma_chief_medical_officer_testifies_on_direct-to-consumer_advertising.
   Google Scholar
• Mintzes B. Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm? Annu Rev Public Health 2012;33:259–77. doi: 10.1146/annurev-publhealth-031811-124540
   PubMed Web of Science ®Google Scholar
• Kaiser Family Foundation. Public views of direct-to-consumer prescription drug advertising. Mollyann Brodie, Ph.D., Vice President and Director, Public Opinion and Media Research. Testimony before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Oversight and Investigations [updated 2008; cited 2015 Apr 1]. Available from: http://www.kff.org/kaiserpolls/upload/7774.pdf.
   Google Scholar
• Jin HS. Antidepressant direct-to-consumer prescription drug advertising and public stigma of depression: the mediating role of perceived prevalence of depression. Int J Advert 2015;34(2):350–65.
   Web of Science ®Google Scholar
• Corrigan PW, Kosyluk KA, Konadu Fokuo J, Park JH. How does direct to consumer advertising affect the stigma of mental illness? Community Ment Health J 2014;50:792–9. doi: 10.1007/s10597-014-9698-7
   PubMed Web of Science ®Google Scholar
• Obermiller C, Spangenberg ER. Development of a scale to measure consumer skepticism toward advertising. J Consum Psychol 1998;7:159–86. doi: 10.1207/s15327663jcp0702_03
   Google Scholar
• Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med 2007;357:673–81. doi: 10.1056/NEJMsa070502
   PubMed Web of Science ®Google Scholar
• Kang H, An S. How direct-to-consumer drug websites convey disease information: analysis of stigma-reducing components. J Health Commun 2013;18:1477–91. doi: 10.1080/10810730.2013.798378
   PubMed Web of Science ®Google Scholar
• Keyes KM, Hatzenbuehler ML, McLaughlin KA, Link B, Olfson M, Grant BF, et al. Stigma and treatment for alcohol disorders in the United States. Am J Epidemiol 2010;172:1364–72. doi: 10.1093/aje/kwq304
   PubMed Web of Science ®Google Scholar
• Ball JG, Liang A, Lee AN. Potential for stigma reduction through direct-to-consumer prescription drug advertising: an exploratory content analysis of television commercials. J Curr Issues Res 2014;35:190–208. doi: 10.1080/10641734.2014.900289
   Google Scholar
• Payton AR, Thoits PA. Medicalization, direct-to-consumer advertising, and mental illness stigma. Soc Ment Health 2011;1(1):55–70. doi: 10.1177/2156869310397959
   Web of Science ®Google Scholar
• Goffman E. Stigma: notes of the management of spoiled identity. Englewood Cliffs, NJ: Prentice Hall; 1963.
   Google Scholar
• An S, Kang H. Stigma-reducing components in direct-to-consumer prescription ads: onset controllability, offset controllability, and recategorization. Health Commun 2011;26:468–78. doi: 10.1080/10410236.2011.554169
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. Mental health: a report of the surgeon general. Rockville, MD: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health; 1999.
   Google Scholar
• Corrigan PW, Penn DL. Lessons from social psychology on discrediting psychiatric stigma. Am Psychol 1999;54:765–76. doi: 10.1037/0003-066X.54.9.765
   PubMed Web of Science ®Google Scholar
• Puhl RM, Heuer CA. Obesity stigma: important considerations for public health. Am J Public Health 2010;100:1019–28. doi: 10.2105/AJPH.2009.159491
   PubMed Web of Science ®Google Scholar
• Tversky A, Kahneman D. Availability: a heuristic for judging frequency and probability. Cogn Psychol 1973;5:207–32. doi: 10.1016/0010-0285(73)90033-9
   Web of Science ®Google Scholar
• An S. Antidepressant direct-to-consumer advertising and social perception of the prevalence of depression: application of the availability heuristic. Health Commun 2008;23:499–505. doi: 10.1080/10410230802342127
   PubMed Web of Science ®Google Scholar
• Cialdini RB. Influence: science and practice. Boston, MA: Allyn and Bacon; 2001.
   Google Scholar
• Ditto PH, Jemmott JB. From rarity to evaluative extremity: effects of prevalence information on evaluations of positive and negative characteristics. J Pers Soc Psychol 1989;57(1):16–26. doi: 10.1037/0022-3514.57.1.16
   PubMed Web of Science ®Google Scholar
• Priestley J, McPherson S. Experiences of adults providing care to a partner or relative with depression: a meta-ethnographic synthesis. J Affect Disord 2016;192:41–9. doi: 10.1016/j.jad.2015.12.011
   PubMed Web of Science ®Google Scholar
• Corrigan PW, Watson AC. At issue: stop the stigma: call mental illness a brain disease. Schizophr Bull 2004;30 (July):477–9. doi: 10.1093/oxfordjournals.schbul.a007095
   PubMed Web of Science ®Google Scholar
• Penn DL, Guynan K, Daily T, Spaulding WD, Garbin CP, Sullivan M. Dispelling the stigma of schizophrenia: what sort of information is best? Schizophr Bull 1994;20 (May):567–78. doi: 10.1093/schbul/20.3.567
   PubMed Web of Science ®Google Scholar
• Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affair 2000;19(2):110–28. doi: 10.1377/hlthaff.19.2.110
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics. Health, United States, 2010: with special feature on death and dying. Hyattsville, MD: National Center for Health Statistics; 2011. Available from: http://www.cdc.gov/nchs/data/hus/hus10.pdf.
   Google Scholar
• Shrum LJ. The implications of survey method for measuring cultivation effects. Human Commun Res 2007;33:64–80.
   Web of Science ®Google Scholar
• Reinke RR, Corrigan PW, Leonhard C, Lundin RK, Kubiak MA. Examining two aspects of contact on the stigma of mental illness. J Soc Clin Psychol 2004;23 (June):377–89. doi: 10.1521/jscp.23.3.377.35457
   Web of Science ®Google Scholar
• Anuar MM, Mohamad O. Effects of skepticism on consumer response toward cause-related marketing in Malaysia. Int Bus Res 2012;5(9):98–105. doi: 10.5539/ibr.v5n9p98
   Google Scholar
• Diehl S, Mueller B, Terlutter R. Skepticism toward pharmaceutical advertising in the U.S. and Germany. Cross-cultural buyer behavior. Adv Int Market 2007;18:31–60. doi: 10.1016/S1474-7979(06)18002-3
   Google Scholar
• Diehl S, Mueller B, Terlutter R. Consumer responses towards non-prescription and prescription drug advertising in the US and Germany. Int J Advert 2008;27:99–131.
   Web of Science ®Google Scholar
• DeLorme DE, Huh J, Reid LN. Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources. Health Market Q 2009;26:293–314. doi: 10.1080/07359680903304278
   PubMedGoogle Scholar
• Lee M, King KW, Reid LN. Factors influencing consumers’ attitudinal and behavioral responses to direct-to-consumer and over-the-counter drug advertising. J Health Commun 2015;20:431–44. doi: 10.1080/10810730.2014.965367
   PubMed Web of Science ®Google Scholar
• Griffiths KM, Christensen H, Jorm AF, Evans K, Groves C. Effect of web-based depression literacy and cognitive-behavioural therapy interventions on stigmatising attitudes to depression: randomised controlled trial. Br J Psychiat 2004;185:342–9. doi: 10.1192/bjp.185.4.342
   PubMed Web of Science ®Google Scholar
• Huh J, DeLorme DE, Reid LN. Factors affecting trust in on-line prescription drug information and impact of trust on behavior following exposure to DTC advertising. J Health Commun 2005;10:711–31. doi: 10.1080/10810730500326716
   PubMed Web of Science ®Google Scholar
• Aiken LS, West SG. Multiple regression: testing and interpreting interactions. Thousand Oaks, CA: Sage; 1991.
   Google Scholar
• Corrigan PW, River LP, Lundin RK, Penn DL, Uphoff-Wasowski K, Campion J, et al. Three strategies for changing attributions about severe mental illness. Schizophr Bull 2001;27 (March):187–95. doi: 10.1093/oxfordjournals.schbul.a006865
   PubMed Web of Science ®Google Scholar
• Brown K, Bradley LJ. Reducing the stigma of mental illness. J Ment Health Couns 2002;24(1):81–7.
   Google Scholar
• Corrigan PW. Mental health stigma as social attribution: implications for research methods and attitude change. Clin Psychol Sci Pract 2000;7:48–67. doi: 10.1093/clipsy.7.1.48
   Web of Science ®Google Scholar
• Lewin B. Patient satisfaction with physician responses during interactions prompted by pharmaceutical advertisements. Soc Sci J 2013;50:491–500. doi: 10.1016/j.soscij.2013.03.002
   Web of Science ®Google Scholar
• Sumpradit N, Ascione FJ, Bagozzi RP. A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising. Clin Ther 2004;26(1):135–54. doi: 10.1016/S0149-2918(04)90014-8
   PubMed Web of Science ®Google Scholar